Outcomes in Renal Cell Carcinoma With IVC Thrombectomy: A Multiteam Analysis Between an NCI-Designated Cancer Center and a Quaternary Care Teaching Hospital

Abstract

Introduction

Interteam performance and Clavien-Dindo (C-D) complications in renal cell carcinoma with inferior vena cava thrombectomy (RCC-IVCT) have not been reported. We aimed to describe complications by the degree of complexity and surgical teams in a collaborative effort between a National Cancer Institute-designated Comprehensive Cancer Center and a Quaternary Care Teaching Hospital.

Methods

Between January 2011 and May 2019, 73 consecutive RCC-IVCT were included. C-D grades III or higher were captured. Teams involved were urologic-oncology, vascular, hepatobiliary/transplant, and cardiothoracic. The Mayo Clinic tumor thrombus classification was used.

Results

Overall complication rate was 42% (n = 31). Nineteen percent had grade III, 18% had grade IV, and 6% had grade V complications. Patients with level IV thrombus had the highest in-hospital mortality rate (75%). Thrombus level did not show a correlation to complication rates (14% level I, 45% level II, 32% level III, 42% level IV). A positive correlation found between the number of teams involved and complication rates (35% with 2-team, 59% with 3-team, P = .059). Thromboembolic events (6% vs 24%, P = .02) and disposition other than home (22% vs 48%, P = .01) were statistically lower for the 2-team groups. Two-team in-hospital mortality was 1/51 (2%) versus 3-team (3/22,14%, (P = .07). No statistical differences were found in infections, thromboembolic events, and grades of complications between surgical teams.

Conclusions

Despite similar interteam performance, the consistency of surgeons in high complexity cases could improve outcomes further. Complexity was higher for hepatobiliary/transplant and cardiothoracic teams. A combination of intraoperative events and patient selection (comorbidities and age) contributed to death. Overall, in-hospital mortality was lower than in most reported series.

Keywords

renal cell carcinoma multi-team approach outcomes

Get full access to this article

View all access options for this article.

References

Petejova

Martinek

. Renal cell carcinoma: review of etiology, pathophysiology and risk factors. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2016;160(2):183-194.doi:10.5507/bp.2015.050

http://www.ncbi.nlm.nih.gov/pubmed/26558360

Ljungberg

Bensalah

Canfield

et al. EAU guidelines on renal cell carcinoma: 2014 update. Eur Urol. 2015;67(5):913-924.doi:10.1016/j.eururo.2015.01.005

http://www.ncbi.nlm.nih.gov/pubmed/25616710

Adams

LC.

Ralla

Bender

Y-NY

et al. Renal cell carcinoma with venous extension: prediction of inferior vena cava wall invasion by MRI. Cancer Imaging. 2018;18(1):17.doi:10.1186/s40644-018-0150-z

http://www.ncbi.nlm.nih.gov/pubmed/29724245

Siegel

RL.

Miller

KD.

Jemal

. Cancer statistics, 2019. CA Cancer J Clin. 2019;69(1):7-34.doi:10.3322/caac.21551

http://www.ncbi.nlm.nih.gov/pubmed/30620402

Haidar

GM.

Hicks

TD.

El-Sayed

HF.

Davies

. Treatment options and outcomes for caval thrombectomy and resection for renal cell carcinoma. J Vasc Surg Venous Lymphat Disord. 2017;5(3):430-436.doi:10.1016/j.jvsv.2016.12.011

http://www.ncbi.nlm.nih.gov/pubmed/28411712

Lambert

EH.

Pierorazio

PM.

Shabsigh

et al. Prognostic risk stratification and clinical outcomes in patients undergoing surgical treatment for renal cell carcinoma with vascular tumor thrombus. Urology. 2007;69(6):1054-1058.doi:10.1016/j.urology.2007.02.052

http://www.ncbi.nlm.nih.gov/pubmed/17572185

Abel

EJ.

Thompson

RH.

Margulis

et al. Perioperative outcomes following surgical resection of renal cell carcinoma with inferior vena cava thrombus extending above the hepatic veins: a contemporary multicenter experience. Eur Urol. 2014;66(3):584-592.doi:10.1016/j.eururo.2013.10.029

http://www.ncbi.nlm.nih.gov/pubmed/24262104

Gayed

BA.

Youssef

Darwish

et al. Multi-disciplinary surgical approach to the management of patients with renal cell carcinoma with venous tumor thrombus: 15 year experience and lessons learned. BMC Urol. 2016;16(1):43 doi:10.1186/s12894-016-0157-3

27435269

Rehman

ZU.

Ather

MH.

Aziz

. Surgical interventions for renal cell carcinoma with thrombus extending into the inferior vena cava: a multidisciplinary approach. Ann Vasc Dis. 2019;12(1):55-59.doi:10.3400/avd.oa.18-00150

http://www.ncbi.nlm.nih.gov/pubmed/30931058

10.

Lawindy

SM.

Kurian

Kim

et al. Important surgical considerations in the management of renal cell carcinoma (RCC) with inferior vena cava (IVC) tumour thrombus. BJU Int. 2012;110(7):926-939.doi:10.1111/j.1464-410X.2012.11174.x

http://www.ncbi.nlm.nih.gov/pubmed/22540179

11.

Hatakeyama

Yoneyama

Hamano

et al. Prognostic benefit of surgical management in renal cell carcinoma patients with thrombus extending to the renal vein and inferior vena cava: 17-year experience at a single center. BMC Urol. 2013;13:47 doi:10.1186/1471-2490-13-47

12.

Clavien

PA.

Barkun

de Oliveira

et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg. 2009;250(2):187-196.doi:10.1097/SLA.0b013e3181b13ca2

http://www.ncbi.nlm.nih.gov/pubmed/19638912

13.

Mehaffey

JH.

Hawkins

RB.

Mullen

et al. Access to quaternary care surgery: implications for accountable care organizations. J Am Coll Surg. 2017;224(4):525-529.doi:10.1016/j.jamcollsurg.2016.12.017

http://www.ncbi.nlm.nih.gov/pubmed/28017810

14.

Toren

Abouassaly

Timilshina

et al. Results of a national population-based study of outcomes of surgery for renal tumors associated with inferior vena cava thrombus. Urology. 2013;82(3):572-578.doi:10.1016/j.urology.2013.04.054

http://www.ncbi.nlm.nih.gov/pubmed/23987150